Professor Vicki Flenady

Preventing stillbirth: the Australian Safe Baby Bundle

Funding 2019: $3,000,000

Program: Accelerated Research Programs

 

Professor Juergen Goetz

Therapeutic Ultrasound for the Treatment of Brain Disorders

Program: Frontier Health and Medical Research Program

Funded 2019: $1,000,000

 

Professor Juergen Goetz

Clem Jones Centre for Ageing Dementia Research

Funded 2019: $10,000,000

Program: Accelerated Research Initiative

 

Dr Matthew Gullo

iAx: Instant assessment and personalised feedback in alcohol use disorder       

Funding 2019: $181,066

Program: Next Generation Clinical Researchers Program

 

Dr Jack Bell

Scaling, spreading, and sustaining The Systematised, Interdisciplinary Malnutrition Program for impLementationand Evaluation (SIMPLE) - a multi-site implementation program

Funding 2019: $181,066

Program: Next Generation Clinical Researchers Program

 

Professor Kwun Fong

Early diagnosis and treatment of lung cancer

Funding 2019: $495,211

Program: Next Generation Clinical Researchers Program

 

Professor Andreas Schibler

Improving Paediatric Critical Care Outcome

Funding 2019: $353,722

Program: Next Generation Clinical Researchers Program

 

Dr Wen Xu

A Randomised Phase II Trial of Adjuvant Avelumab in Patients with Early Stage Merkel Cell Carcinoma

Funding 2019: $1,632,096

Program: Rare Cancers, Rare Diseases and Unmet Need

 

Professor David Johnson

The TEACH-PD study: a Targeted Education ApproaCH to improve Peritoneal Dialysis outcomes

Funding 2019: $2,383,207

Program: Rare Cancers, Rare Diseases and Unmet Need

 

Professor Maher Gandhi

An Open Label, Multicentre, Phase One Study Incorporating Early Application of CAR T cells for Primary Refractory Aggressive Lymphoma

Funding 2019: $3,496,967

Program: Rare Cancers, Rare Diseases and Unmet Need

 

Professor Peter Soyer

Personalised Early Detection of Melanoma

Funded 2018: $585,269

Program: Next Generation Clinical Researchers

 

Professor David Paterson

Cluster randomised trial of a multimodal intervention to reduce antimicrobial use in residential aged care facilities

Funded 2018: $1,199,976

Program: Tackling Antimicrobial Resistance

 

Professor Maher Gandhi

An Open label, Multicentre, Phase I study of Ibrutinib, Rituximab and EBV specific T-cells in Patients with EBV-positive Primary or Secondary CNS Lymphoma unsuitable for standard therapies.

Funded 2018: $1,642,389

Program: Lifting Clinical Trials and Registries Capacity

 

Professor Claire Wainwright

A platform clinical trial approach to the management of Mycobacterium abscessus complex (MABSC)

Funded 2018: $2,091,178

Program: Lifting Clinical Trials and Registries Capacity

 

Professor Janet Hardy

Medicinal Cannabinoids to Relieve Symptom Burden in the Palliative Care of Patients with Advanced Cancer

Funded 2018: $1,363,040

Program: Lifting Clinical Trials and Registries Capacity